Braive Growth Modulation System Break-Off Set Screws - Product Usage: intended to limit further p...

FDA Device Recall #Z-1797-2021 — Class II — April 27, 2021

Recall Summary

Recall Number Z-1797-2021
Classification Class II — Moderate risk
Date Initiated April 27, 2021
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Medtronic Sofamor Danek USA, Inc
Location Memphis, TN
Product Type Devices
Quantity 162 UNITS

Product Description

Braive Growth Modulation System Break-Off Set Screws - Product Usage: intended to limit further progression of the spinal curvature and provide correction of the thoracic curve while allowing continued skeletal growth by compression of the convex side of the scoliotic curve.

Reason for Recall

Product is impacted by a thread profile defect due to a manufacturing issue.

Distribution Pattern

International distribution in the countries of France, Switzerland and Jordan. No US distribution.

Lot / Code Information

CT20L012 and CT20L020. CT20L012 EXP 2 DEC 2028 CT20L020 EXP 11 DEC 2028

Other Recalls from Medtronic Sofamor Danek USA, Inc

Recall # Classification Product Date
Z-2363-2023 Class II CD HORIZON Spinal System Solera Awl Tip Tap, RE... Jul 12, 2023
Z-1440-2021 Class II Endoskeleton TC Interbody System with Titan nan... Mar 17, 2021
Z-1439-2021 Class II Endoskeleton TC Interbody System with Titan nan... Mar 17, 2021

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.